Correction to: Identifying Safety Thresholds for Immunosuppressive Drugs: Applying Insights from Primary Antibody Deficiencies to Mitigate Adverse Events in Secondary Antibody Deficiencies Using Mathematical Modeling of Preclinical and Early Clinical Data

Detalles Bibliográficos
Autores principales: Kareva, Irina, Zutshi, Anup, Mateo, Cristina Vazquez, Papasouliotis, Orestis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599355/
https://www.ncbi.nlm.nih.gov/pubmed/34581976
http://dx.doi.org/10.1007/s13318-021-00719-8
_version_ 1784600931803856896
author Kareva, Irina
Zutshi, Anup
Mateo, Cristina Vazquez
Papasouliotis, Orestis
author_facet Kareva, Irina
Zutshi, Anup
Mateo, Cristina Vazquez
Papasouliotis, Orestis
author_sort Kareva, Irina
collection PubMed
description
format Online
Article
Text
id pubmed-8599355
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-85993552021-11-24 Correction to: Identifying Safety Thresholds for Immunosuppressive Drugs: Applying Insights from Primary Antibody Deficiencies to Mitigate Adverse Events in Secondary Antibody Deficiencies Using Mathematical Modeling of Preclinical and Early Clinical Data Kareva, Irina Zutshi, Anup Mateo, Cristina Vazquez Papasouliotis, Orestis Eur J Drug Metab Pharmacokinet Correction Springer International Publishing 2021-09-28 2021 /pmc/articles/PMC8599355/ /pubmed/34581976 http://dx.doi.org/10.1007/s13318-021-00719-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/ Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Correction
Kareva, Irina
Zutshi, Anup
Mateo, Cristina Vazquez
Papasouliotis, Orestis
Correction to: Identifying Safety Thresholds for Immunosuppressive Drugs: Applying Insights from Primary Antibody Deficiencies to Mitigate Adverse Events in Secondary Antibody Deficiencies Using Mathematical Modeling of Preclinical and Early Clinical Data
title Correction to: Identifying Safety Thresholds for Immunosuppressive Drugs: Applying Insights from Primary Antibody Deficiencies to Mitigate Adverse Events in Secondary Antibody Deficiencies Using Mathematical Modeling of Preclinical and Early Clinical Data
title_full Correction to: Identifying Safety Thresholds for Immunosuppressive Drugs: Applying Insights from Primary Antibody Deficiencies to Mitigate Adverse Events in Secondary Antibody Deficiencies Using Mathematical Modeling of Preclinical and Early Clinical Data
title_fullStr Correction to: Identifying Safety Thresholds for Immunosuppressive Drugs: Applying Insights from Primary Antibody Deficiencies to Mitigate Adverse Events in Secondary Antibody Deficiencies Using Mathematical Modeling of Preclinical and Early Clinical Data
title_full_unstemmed Correction to: Identifying Safety Thresholds for Immunosuppressive Drugs: Applying Insights from Primary Antibody Deficiencies to Mitigate Adverse Events in Secondary Antibody Deficiencies Using Mathematical Modeling of Preclinical and Early Clinical Data
title_short Correction to: Identifying Safety Thresholds for Immunosuppressive Drugs: Applying Insights from Primary Antibody Deficiencies to Mitigate Adverse Events in Secondary Antibody Deficiencies Using Mathematical Modeling of Preclinical and Early Clinical Data
title_sort correction to: identifying safety thresholds for immunosuppressive drugs: applying insights from primary antibody deficiencies to mitigate adverse events in secondary antibody deficiencies using mathematical modeling of preclinical and early clinical data
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599355/
https://www.ncbi.nlm.nih.gov/pubmed/34581976
http://dx.doi.org/10.1007/s13318-021-00719-8
work_keys_str_mv AT karevairina correctiontoidentifyingsafetythresholdsforimmunosuppressivedrugsapplyinginsightsfromprimaryantibodydeficienciestomitigateadverseeventsinsecondaryantibodydeficienciesusingmathematicalmodelingofpreclinicalandearlyclinicaldata
AT zutshianup correctiontoidentifyingsafetythresholdsforimmunosuppressivedrugsapplyinginsightsfromprimaryantibodydeficienciestomitigateadverseeventsinsecondaryantibodydeficienciesusingmathematicalmodelingofpreclinicalandearlyclinicaldata
AT mateocristinavazquez correctiontoidentifyingsafetythresholdsforimmunosuppressivedrugsapplyinginsightsfromprimaryantibodydeficienciestomitigateadverseeventsinsecondaryantibodydeficienciesusingmathematicalmodelingofpreclinicalandearlyclinicaldata
AT papasouliotisorestis correctiontoidentifyingsafetythresholdsforimmunosuppressivedrugsapplyinginsightsfromprimaryantibodydeficienciestomitigateadverseeventsinsecondaryantibodydeficienciesusingmathematicalmodelingofpreclinicalandearlyclinicaldata

Ejemplares similares